Every 8-K that My Size, Inc (MYSZ) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow MYSZ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MYSZ filings page.
My Size, Inc. (MYSZ) entered into a securities purchase agreement for a private placement of up to 1,308,901 unregistered pre-funded warrants together with Series C and Series D warrants, at an offering price of $1.91 per pre-funded warrant and associated Series Warrants, for aggregate gross proceeds of approximately $2.5 million. The pre-funded warrants are immediately exercisable at $0.001 per share and remain outstanding until fully exercised, while the Series C and Series D warrants are immediately exercisable at $1.66 per share, with five-year and 18‑month terms, respectively, starting from the effective date of a resale registration statement. H.C. Wainwright & Co. is acting as exclusive placement agent and will receive cash fees, expense reimbursements, and 91,623 placement agent warrants; the company has agreed to file a resale registration statement within 15 days and obtain effectiveness within specified SEC review timelines, and the offering is expected to close on or about September 16, 2026, subject to customary conditions.
My Size, Inc. (MYSZ) reported that Nasdaq has notified the company it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000 for continued listing on the Nasdaq Capital Market. My Size reported $2,347,000 of stockholders’ equity as of June 30, 2026 in its Form 10‑Q.
The notice does not immediately affect the trading of My Size’s common stock on Nasdaq. The company has 45 days, until October 9, 2026, to submit a compliance plan. If Nasdaq accepts the plan, My Size may receive up to 180 days from August 25, 2026, through February 21, 2027, to regain compliance. If My Size cannot regain compliance, Nasdaq staff would issue a delisting determination, which the company could appeal to a Nasdaq Hearings Panel, temporarily staying any delisting action.
MySize, Inc. reported strong top-line growth but weaker profitability for the quarter and six months ended June 30, 2026. Second-quarter revenue rose 53% year-over-year to $3.07 million, and first-half revenue grew 57% to $5.46 million, driven by expansion in fashion e-commerce, the Percentil resale platform and contributions from Ten Peacks.
Despite this growth, profitability deteriorated. Quarterly gross profit was $973,000 and gross margin fell to 31.7% from 56.0%, reflecting a revenue mix shift toward lower-margin commerce activities. Operating loss widened to $1.72 million and net loss to $1.75 million for the quarter; first-half net loss was $3.13 million. Operating expenses increased across R&D, sales and marketing, and G&A as the platform scaled.
The SaaS Solutions segment remained highly profitable, generating 86% gross margin on $211,000 of revenue, and net cash used in operating activities for the first half improved to $1.97 million from $2.31 million. As of June 30, 2026, MySize held $453,000 in cash and cash equivalents and $258,000 in restricted cash, and disclosed that it expects continued losses and negative operating cash flows and will require additional capital to support its operations and growth strategy.
My Size, Inc. approved and implemented a 1-for-8 reverse stock split of its common stock. A Certificate of Amendment was filed in Delaware, and the split became effective as of 4:30 p.m. Eastern Time on August 12, 2026. The stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market on August 13, 2026, continuing under the symbol MYSZ with a new CUSIP 62844N 505.
Every eight shares of issued and outstanding common stock were automatically converted into one share, with no change to par value. Outstanding options and warrants were proportionately adjusted. No fractional shares will be issued; instead, holders receive cash based on the August 12, 2026 Nasdaq closing price, as adjusted for the split. The number of authorized shares is unchanged, while outstanding shares are reduced from approximately 4.8 million to approximately 600 thousand. The company states the split is intended to increase the per-share price to regain compliance with Nasdaq’s continued listing requirements and potentially broaden its institutional investor base.
My Size, Inc. entered into an Equity Purchase Agreement with Square Gate Capital Master Fund, LLC - Series 5, giving it the right, but not the obligation, to sell up to $10,000,000 of common stock over a 36‑month period ending no later than August 5, 2029. Sales are initiated at the company’s discretion via regular or intraday put notices, subject to conditions and a 4.99% beneficial ownership cap.
An Exchange Cap initially limits issuance to 1,024,597 shares, or 19.99% of shares outstanding on the execution date, unless stockholders approve more or the average sale price reaches at least $0.3706. My Size paid a $100,000 commitment fee in 269,229 shares, with possible true‑up shares. Purchase prices are set at 96.5% of the lowest VWAP for regular puts or 100% of the lowest trade during intraday periods. The company agreed to standstill, variable‑rate, and competing equity line restrictions that can limit other equity financings, while the investor agreed not to short or hedge the stock. My Size will file a Form S‑1 within 30 days to register resale of the commitment shares, and any proceeds from future share sales will be used for working capital and general corporate purposes.
My Size, Inc. reported the results of its 2026 annual stockholder meeting. A quorum of 2,023,301 shares of common stock was represented. Stockholders elected Class II directors Oron Branitzky and Guy Zimmerman, each receiving more than 1.07 million votes in favor, to serve three-year terms.
Stockholders approved the advisory vote on executive compensation with 968,586 votes For. They also granted the Board discretionary authority to implement one or more Reverse Stock Splits of the common stock at ratios from 1-for-2 up to 1-for-30, which may be effected by July 21, 2027, including the treatment of fractional shares. An amendment to authorize issuance of blank check preferred stock did not receive the required majority of outstanding shares and was not approved. Stockholders ratified the appointment of Somekh Chaikin as independent public accountant with 1,901,844 votes For for the fiscal year ending December 31, 2026.
MySize, Inc. reported strong top-line growth for the first quarter of 2026 while remaining unprofitable. Revenue rose 62% year-over-year to about $2.39 million, driven mainly by fashion e-commerce operations and the consolidation of Percentil.
Gross profit more than doubled to roughly $940 thousand, with gross margin improving to 39.3% from 28.4%, reflecting better profitability on each sale. Operating expenses also increased across research and development, sales and marketing, and general and administrative functions, supporting technology investments and integration activities.
Net loss widened to approximately $1.48 million from about $1.06 million a year earlier, and cash, cash equivalents and restricted cash totaled roughly $910 thousand as of March 31, 2026. Management highlighted continued integration of Percentil and ShoeSize.Me and growth at Orgad and Naiz Fit as MySize builds an AI-driven, multi-channel fashion technology platform.
My Size, Inc. reported that Nasdaq notified the company its common stock closed below $1.00 for 30 consecutive trading days, triggering a minimum bid price deficiency. The company has 180 days, until August 31, 2026, to regain compliance by maintaining a closing bid of at least $1.00 for 10 consecutive business days.
The company said the notice does not affect its current operations, customers, financial position, or the continued trading of its shares on Nasdaq under the symbol MYSZ. Management reiterated a focus on execution, revenue quality, and higher-margin activities. My Size generated approximately $10 million of revenue in 2025, with its Orgad business operating at about 40% gross margin, and its 10peaks subsidiary generating roughly $150,000 of revenue at about 65% gross margin before operating expenses. Management currently estimates 10peaks could reach around $3 million in annual revenue based on current commercial assumptions.
My Size, Inc. received a notice from Nasdaq that its stock no longer meets the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market. This follows 30 consecutive business days with a closing bid price below that level.
The company has 180 calendar days, until August 31, 2026, to regain compliance by achieving a closing bid of at least $1.00 for 10 consecutive business days. If it still does not comply, it may qualify for an additional 180-day period if it meets other Nasdaq listing standards.
If compliance is not regained, Nasdaq may move to delist the shares, though My Size would have the right to appeal. The company plans to monitor its share price and is considering options such as a potential reverse stock split to restore compliance.
My Size, Inc. (MYSZ) furnished third‑quarter results. The company reported that it issued a press release covering its results of operations for the quarter ended September 30, 2025, and furnished it as Exhibit 99.1 to this Form 8‑K.
The company noted the information under Item 2.02, including Exhibit 99.1, is being furnished and not deemed filed under the Exchange Act or incorporated by reference under the Securities Act except as expressly stated.
My Size, Inc. reported results of its 2025 annual stockholder meeting. Stockholders elected two Class I directors, Arik Kaufman and Roy Golan, to serve three-year terms, with each receiving over 333,000 votes in favor and more than 950,000 broker non-votes recorded.
Stockholders approved an amendment to the 2017 Equity Incentive Plan to increase the share reserve for awards to 756,691 shares of common stock from 130,000 shares, and also approved an evergreen provision. From January 1, 2026 through January 1, 2029, the plan’s share reserve will automatically increase each year by the lesser of 5% of the common shares outstanding at the prior year-end or a smaller amount set by the board.
In addition, stockholders ratified the appointment of Somekh Chaikin as independent public accountant for the fiscal year ending December 31, 2025, with more than 1.22 million votes in favor.
My Size, Inc. furnished an update on its recent performance by submitting a Form 8-K that includes a press release with its results of operations for the second quarter ended June 30, 2025. The company states that the press release, dated August 15, 2025, is provided as Exhibit 99.1 and is incorporated by reference in the report. The information is designated as “furnished” rather than “filed” under the Exchange Act, which limits its use for certain liability purposes and future incorporations unless specifically referenced.